Sinopharm Group Co. Ltd. (FRA:X2S)

Market Cap	6.47B
Revenue (ttm)	68.44B
Net Income (ttm)	809.54M
Shares Out	n/a
EPS (ttm)	0.26
PE Ratio	8.00
Forward PE	6.83
Dividend	0.08 (4.05%)
Ex-Dividend Date	Jun 16, 2025

Volume	3,000
Average Volume	2,171
Open	2.156
Previous Close	2.066
Day's Range	2.140 - 2.156
52-Week Range	1.934 - 2.705
Beta	n/a
RSI	56.57
Earnings Date	Oct 31, 2025

About Sinopharm Group

Sinopharm Group Co. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and healthcare products, and medical devices in the People’s Republic of China. The company operates through four segments: Pharmaceutical Distribution, Medical Devices Distribution, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment distributes pharmaceutical products to hospitals, other distributors, retail pharmacy stores, and clinics. This segment also offers distribution, logistics, and other value-added...

• Industry: Drugs, Drug Proprietaries, and Druggists' Sundries
• Founded: 2003
• Employees: 108,217
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: X2S

Financial Performance

In 2024, Sinopharm Group's revenue was 584.51 billion, a decrease of -2.02% compared to the previous year's 596.57 billion. Earnings were 7.05 billion, a decrease of -22.14%.

Financial numbers in CNY